Wang, Christina
- Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center · Obstetrics & Gynecology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,933
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,933
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wang, Christina as a PI. Multi-PI records show the full award amount for context.
- 275201300024I-P00005-27500007-1N01Contact PICCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE$2.8Maward amount
- 275201300024I-P00012-27500002-1N01Contact PICCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, DMAU$82.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Wang, Christina as a PI.
FY2023 award administered by Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardLundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- 2010$500K Cumulative Funding
- 2010$1M Cumulative Funding
- 2010$2M Cumulative Funding
- 2010Entered Top 50% NationallyRanked #4913
- 2010Entered Top 25% NationallyRanked #4913
- 2014$5M Cumulative Funding
- 2014Entered Top 10% NationallyRanked #1621
- 2017$10M Cumulative Funding